Chronic sympathoexcitation through loss of vav3, a rac1 activator, results in divergent effects on metabolic syndrome and obesity depending on diet

Cell Metabolism

Volumn 18, Issue 2, 2013, Pages 199-211

  Menacho Márquez, Mauricio ^a   Nogueiras, Rubén ^b   Fabbiano, Salvatore ^a   Sauzeau, Vincent ^a   Al Massadi, Omar ^b   Diéguez, Carlos ^b   Bustelo, Xosé R ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; NORADRENALIN; PROTEIN; UNCLASSIFIED DRUG; VAV3 PROTEIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CELL TRANSDIFFERENTIATION; DIET; FATTY LIVER; HYPERTENSION; LIPID DIET; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; THERMOGENESIS;

ADIPOCYTES, BROWN; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET; DIET, HIGH-FAT; ENERGY METABOLISM; EPINEPHRINE; FATTY ACIDS; FATTY LIVER; HYPERTENSION; LIVER; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; NOREPINEPHRINE; OBESITY; PROTO-ONCOGENE PROTEINS C-VAV; RAC1 GTP-BINDING PROTEIN; SYMPATHETIC NERVOUS SYSTEM; THERMOGENESIS;

EID: 84881360179     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.07.001     Document Type: Article

References (29)

1. J.L. Bos, H. Rehmann, and A. Wittinghofer GEFs and GAPs: critical elements in the control of small G proteins Cell 129 2007 865 877
2. M.S. Brown, and J.L. Goldstein Selective versus total insulin resistance: a pathogenic paradox Cell Metab. 7 2008 95 96
3. B. Cannon, and J. Nedergaard Brown adipose tissue: function and physiological significance Physiol. Rev. 84 2004 277 359
4. X.Y. Dong, and S.Q. Tang Insulin-induced gene: a new regulator in lipid metabolism Peptides 31 2010 2145 2150
5. G.M. Doody, S.E. Bell, E. Vigorito, E. Clayton, S. McAdam, R. Tooze, C. Fernandez, I.J. Lee, and M. Turner Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation Nat. Immunol. 2 2001 542 547
6. P.J. Fernandez-Marcos, and J. Auwerx Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis Am. J. Clin. Nutr. 93 2011 884S-90
7. A. Girousse, G. Tavernier, C. Valle, C. Moro, N. Mejhert, A.L. Dinel, M. Houssier, B. Roussel, A. Besse-Patin, and M. Combes Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass PLoS Biol. 11 2013 e1001485
8. P.G. Guyenet The sympathetic control of blood pressure Nat. Rev. Neurosci. 7 2006 335 346
9. P. Hossain, B. Kawar, and M. El Nahas Obesity and diabetes in the developing world - a growing challenge N. Engl. J. Med. 356 2007 213 215
10. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
11. G.W. Lambert, N.E. Straznicky, E.A. Lambert, J.B. Dixon, and M.P. Schlaich Sympathetic nervous activation in obesity and the metabolic syndrome - causes, consequences and therapeutic implications Pharmacol. Ther. 126 2010 159 172
12. C.J. Madden Glucoprivation in the ventrolateral medulla decreases brown adipose tissue sympathetic nerve activity by decreasing the activity of neurons in raphe pallidus Am. J. Physiol. Regul. Integr. Comp. Physiol. 302 2012 R224 R232 10.1152/ajpregu.00449.2011 Published online November 9, 2011
13. G. Mancia, P. Bousquet, J.L. Elghozi, M. Esler, G. Grassi, S. Julius, J. Reid, and P.A. Van Zwieten The sympathetic nervous system and the metabolic syndrome J. Hypertens. 25 2007 909 920
14. J.S. Marino, Y. Xu, and J.W. Hill Central insulin and leptin-mediated autonomic control of glucose homeostasis Trends Endocrinol. Metab. 22 2011 275 285
15. D.E. Moller, and K.D. Kaufman Metabolic syndrome: a clinical and molecular perspective Annu. Rev. Med. 56 2005 45 62
16. S.F. Morrison RVLM and raphe differentially regulate sympathetic outflows to splanchnic and brown adipose tissue Am. J. Physiol. 276 1999 R962 R973
17. S.F. Morrison, K. Nakamura, and C.J. Madden Central control of thermogenesis in mammals Exp. Physiol. 93 2008 773 797
18. G.J. Morton, D.E. Cummings, D.G. Baskin, G.S. Barsh, and M.W. Schwartz Central nervous system control of food intake and body weight Nature 443 2006 289 295
19. N. Movilla, and X.R. Bustelo Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins Mol. Cell. Biol. 19 1999 7870 7885
20. P. Pervanidou, and G.P. Chrousos Metabolic consequences of stress during childhood and adolescence Metabolism 61 2012 611 619
21. J. Robidoux, T.L. Martin, and S. Collins Beta-adrenergic receptors and regulation of energy expenditure: a family affair Annu. Rev. Pharmacol. Toxicol. 44 2004 297 323
22. V. Sauzeau, M.A. Sevilla, J.V. Rivas-Elena, E. de Alava, M.J. Montero, J.M. López-Novoa, and X.R. Bustelo Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction Nat. Med. 12 2006 841 845
23. V. Sauzeau, M. Jerkic, J.M. López-Novoa, and X.R. Bustelo Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice Mol. Biol. Cell 18 2007 943 952
24. V. Sauzeau, J.A.C. Horta-Junior, A.S. Riolobos, G. Fernández, M.A. Sevilla, D.E. López, M.J. Montero, B. Rico, and X.R. Bustelo Vav3 is involved in GABAergic axon guidance events important for the proper function of brainstem neurons controlling cardiovascular, respiratory, and renal parameters Mol. Biol. Cell 21 2010 4251 4263
25. V. Sauzeau, M.A. Sevilla, M.J. Montero, and X.R. Bustelo The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells J. Clin. Invest. 120 2010 315 330
26. W. Shao, and P.J. Espenshade Expanding roles for SREBP in metabolism Cell Metab. 16 2012 414 419
27. A.J. Verberne, and D.M. Sartor Rostroventrolateral medullary neurons modulate glucose homeostasis in the rat Am. J. Physiol. Endocrinol. Metab. 299 2010 E802 E807
28. H. Waki, K.W. Park, N. Mitro, L. Pei, R. Damoiseaux, D.C. Wilpitz, K. Reue, E. Saez, and P. Tontonoz The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression Cell Metab. 5 2007 357 370
29. C.X. Yi, S.E. la Fleur, E. Fliers, and A. Kalsbeek The role of the autonomic nervous liver innervation in the control of energy metabolism Biochim. Biophys. Acta 1802 2010 416 431